Potential of Gene Therapy as a Treatment for Colour Vision Deficiencies: Advances, Challenges, and Prospects

The objective of this research study is to explore the potential of gene therapy as a treatment for colour vision deficiencies, to improve colour discrimination and perception in affected individuals. Gene therapy has emerged as a promising approach for treating colour vision deficiencies, including red-green colour blindness. Gene therapy involves the delivery of therapeutic genes into target cells to correct genetic abnormalities and restore normal cellular function. Cell sensitivity, and improved colour discrimination in animal models. Furthermore, early clinical trials have reported encouraging outcomes, indicating the potential effectiveness and safety of gene therapy in humans. This study provides an overview of the advancements and challenges in gene therapy for colour vision. It highlights the genetic basis of colour blindness, the various gene therapy strategies employed, and the outcomes of preclinical and clinical studies. Gene therapy holds promise as a potential therapeutic avenue for addressing colour vision deficiencies, and ongoing research and clinical trials will continue to shed light on its effectiveness, safety, and long-term outcomes.